Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-29 4:30 pm Unchanged | 13G | VIGIL NEUROSCIENCE INC VIGL | Artal International S.C.A. | 1,811,191 4.9% | 0 (Unchanged) | View |
2024-02-14 4:57 pm Sale | 13G | VIGIL NEUROSCIENCE INC VIGL | CITADEL ADVISORS LLC | 2,161,902 6% | -2,014 (-0.09%) | View |
2024-02-14 11:33 am Sale | 13G | VIGIL NEUROSCIENCE INC VIGL | Deep Track Capital LP | 3,649,726 9.62% | -34,893 (-0.95%) | View |
2024-02-12 5:31 pm Sale | 13G | VIGIL NEUROSCIENCE INC VIGL | Flynn James E | 1,173,523 3.27% | -878,487 (-42.81%) | View |
2024-02-09 5:13 pm Sale | 13G | VIGIL NEUROSCIENCE INC VIGL | Artal International S.C.A. | 1,811,191 5% | -432,161 (-19.26%) | View |
2023-02-14 4:10 pm Purchase | 13G | VIGIL NEUROSCIENCE INC VIGL | Hatteras Venture Partners VI LP | 1,565,578 4.4% | 1,565,578 (New Position) | View |
2023-02-14 08:02 am Purchase | 13G | VIGIL NEUROSCIENCE INC VIGL | CITADEL ADVISORS LLC | 2,163,916 6.1% | 55,196 (+2.62%) | View |
2023-02-10 7:36 pm Sale | 13G | VIGIL NEUROSCIENCE INC VIGL | Artal International S.C.A. | 2,243,352 6.3% | -42,222 (-1.85%) | View |
2023-02-10 4:31 pm Purchase | 13D | VIGIL NEUROSCIENCE INC VIGL | Vida Ventures GP III L.L.C. | 5,015,929 14.1% | 5,015,929 (New Position) | View |
2023-02-10 09:37 am Sale | 13G | VIGIL NEUROSCIENCE INC VIGL | Flynn James E | 2,052,010 5.77% | -2,784 (-0.14%) | View |
2022-12-16 5:22 pm Unchanged | 13D | VIGIL NEUROSCIENCE INC VIGL | Northpond Ventures LP | 4,214,498 11.8% | 0 (Unchanged) | View |
2022-08-26 5:11 pm Purchase | 13G | VIGIL NEUROSCIENCE INC VIGL | BIOTECHNOLOGY VALUE FUND L P | 2,739,727 7.5% | 2,739,727 (New Position) | View |
2022-08-23 4:16 pm Purchase | 13G | VIGIL NEUROSCIENCE INC VIGL | Artal International S.C.A. | 2,285,574 6.4% | 2,285,574 (New Position) | View |
2022-08-22 4:16 pm Purchase | 13G | VIGIL NEUROSCIENCE INC VIGL | Deep Track Capital LP | 3,684,619 9.99% | 3,684,619 (New Position) | View |
2022-08-16 5:19 pm Purchase | 13G | VIGIL NEUROSCIENCE INC VIGL | Flynn James E | 2,054,794 5.78% | 2,054,794 (New Position) | View |
2022-01-21 4:39 pm Purchase | 13D | VIGIL NEUROSCIENCE INC VIGL | Atlas Venture Fund XII L.P. | 4,808,896 17% | 4,808,896 (New Position) | View |
2022-01-21 4:14 pm Purchase | 13G | VIGIL NEUROSCIENCE INC VIGL | CITADEL ADVISORS LLC | 2,108,720 7.5% | 2,108,720 (New Position) | View |
2022-01-19 4:25 pm Purchase | 13D | VIGIL NEUROSCIENCE INC VIGL | Northpond Ventures LP | 4,214,498 14.9% | 4,214,498 (New Position) | View |
2022-01-11 9:33 pm Purchase | 13G | VIGIL NEUROSCIENCE INC VIGL | AMGEN INC AMGN | 3,206,281 11.3% | 3,206,281 (New Position) | View |